September 23, 2026

Eurorscg London

Better Health Today

Ulta Beauty Stock: Still a Bargain After Price Spike

Headquartered in Illinois, Ulta Beauty (ULTA) sells natural beauty products in retail outlets and on the internet. I am bullish on the stock.

Have you ever imagined about investing in a cosmetic retailer? It may possibly seem like a unsafe proposition for the duration of a time of provide-chain bottlenecks, superior inflation, and COVID-19 considerations. Amid this demanding backdrop for stores in basic, and Ulta Elegance in specific, the bull circumstance may perhaps be hard to see proper now.

Just before passing judgment on Ulta Natural beauty, though, it truly is essential to look at the facts and make an educated choice. You could be stunned to find out that the corporation is nevertheless executing strongly in several magnificence-solution classes, which suggests that consumers are even now acquiring tons of makeup, hair-care goods, and so on.

Elegance is only pores and skin deep, as they say, but it looks that buyers discovered Ulta Beauty’s not too long ago posted monetary final results to be very eye-catching. As we’ll see, they gave Ulta Splendor stock a nice boost, but there is even now robust benefit right here for enterprising investors.

On TipRanks, ULTA scores a 10 out of 10 on the Wise Rating spectrum. This signifies a large probable for the inventory to outperform the broader current market.

Dear, nonetheless Low-cost

So, let’s chat about that value raise. Ulta Magnificence inventory has a 52-week selection of $319.05 to $438.63. The inventory traded in the reduced half of that array not very long back, but then just just lately, the potential buyers pushed Ulta Attractiveness stock to $418.

How is this achievable? A vital facts release and steering issuance could have a little something to do with it – but more on that in a moment. Initial, we ought to deal with the issue of whether Ulta Beauty inventory is expensive or low-cost.

On a area stage, a $400-ish inventory unquestionably seems dear. Furthermore, the the latest buying spree pushed the share price toward the higher end of its array. So, Ulta Attractiveness inventory is way too pricey to get now, right?

Not essentially. Even after the share-price tag rally, Ulta Beauty’s trailing 12-thirty day period P/E ratio is 23.26, which is rather reasonable. For this reason, it’s conceivable that this $400-ish inventory essentially offers a good benefit at the present-day share cost.

This is not to advise that any person should obtain a inventory entirely centered on a company’s P/E ratio. The most important factor is to verify the firm’s financials and seem for expansion. Although, can Ulta Elegance exhibit growth all through a time of inflation, pandemic, and source-chain troubles?

In a meeting contact, Ulta Natural beauty President Dave Kimbell answered that issue decisively, declaring, “Fiscal 2022 is off to an remarkable start out with the Ulta Beauty group offering an additional quarter of excellent general performance on top of previous year’s record benefits.” This ought to give us a clue that Ulta Splendor is, certainly, executing on its goals and providing powerful final results in spite of the known problems.

Achievement Across the Board

Decide a metric – any metric. Pretty much where ever you glimpse, Ulta Attractiveness succeeded in its initially-quarter fiscal-year 2022 final results.

For the duration of the meeting phone, Kimbell served up a battery of bullet factors, reporting that Ulta Beauty’s to start with-quarter “net sales greater 21% to $2.3 billion, comp revenue enhanced 18%, functioning revenue greater to 18.7% of revenue and diluted EPS elevated 54% to $6.30 for each share” on a 12 months-about-12 months foundation.

Just those stats by yourself ought to drive some of the Ulta Magnificence stock bears into hibernation for a although. We can presently see why investors acquired the shares and pushed the rate greater, as Ulta Attractiveness is fiscally firing on all cylinders.

Moreover, there is much more to the story as Ulta Natural beauty ended the initially quarter of fiscal 2022 with a nutritious harmony sheet, which includes dollars and income equivalents totaling $654.5 million. Investors ought to also want to know that Ulta Splendor repurchased 331,834 shares of its prevalent stock at a charge of $132.8 million all through the quarter. This self-investment tends to recommend that the enterprise is assured in its future growth.

On the lookout towards the long term, Ulta Natural beauty provided remarkably optimistic assistance for the entire fiscal calendar year of 2022. In conditions of net sales, the firm experienced formerly modeled $9.05 billion to $9.15 billion, but up-to-date the vary to $9.35 billion to $9.55 billion. Moreover, Ulta Beauty is now anticipating total-calendar year equivalent profits growth of 6% to 8%, which is double the former assistance of 3% to 4%.

Turning to the firm’s expected base-line end result, Ulta Natural beauty lifted the guidance for its whole-yr diluted earnings per share from a assortment of $18.20 to $18.70, to $19.20 to $20.10. In between the raised advice and the company’s share buybacks, it really is evident that Ulta Beauty is brimming with self-self esteem – and justifiably so, as the firm’s financials are rock-solid.

Wall Street’s Get

According to TipRanks’ analyst score consensus, ULTA is a Reasonable Acquire, based mostly on 13 Get and 5 Keep ratings. The regular Ulta Beauty cost concentrate on is $467.44, implying 10.48% upside potential.

The Takeaway

Now, you have bullish economic knowledge and guidance that may persuade you to make investments in a premier beauty-solution enterprise. There are problems to contend with, sure, but Ulta Elegance is providing superb effects and planning for a powerful yr.

It just goes to present that you can locate promising investments in sudden areas. Right after all, a stunning accomplishment story during tough occasions is a gorgeous point.

Go through full Disclosure

The sights and opinions expressed herein are the sights and views of the writer and do not always reflect those of Nasdaq, Inc.